Develops absorbable collagen drugs to treat pain, foot infections and adhesions.
Industry: Health Care
First Day Return: 0.0%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 06/19/2014 |
Offer Price | $9.00 |
Price Range $13.00 - $15.00 | |
Offer Shares (mm) | 6.5 |
Deal Size ($mm) | $59 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 07/24/2014 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $59 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | Athlone, Ireland |
Founded | 1997 |
Employees at IPO | 90 |
Website www.innocollinc.com |